Searched for
GLAND PHARMA USFDA
Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Ind...- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- Dr Reddy's Laboratories launches generic Sugammadex injection in the United StatesDr Reddy's Laboratories has launched its generic Sugammadex injection in the United States. This new product reverses muscle relaxant effec...
- Gland Pharma gets USFDA nod for generic sugammadex injectionGland Pharma secured USFDA approval for its sugammadex injection generic version. This drug reverses muscle relaxant effects used during su...
- USFDA issues Form 483 with 3 three observations to Gland Pharma's Visakhapatnam unitGland Pharma Ltd's facility at Visakhapatnam received three Form 483 observations from the USFDA after a recent inspection for sterile APIs...
- Stocks in news: Wipro, Kotak Bank, Zomato, Motilal Oswal, Adani EnergyIT services company Wipro reported 24% growth in its consolidated net profit at Rs 3,354 crore, while revenue from operations rose by a mar...
- Gland Pharma shares rise 5% on receiving US FDA approval for vitamin K deficiency injectableGland Pharma shares rose after receiving FDA approval for phytonadione injectable emulsion, a product used for coagulation disorders. Despi...
- Gland Pharma gets USFDA nod for generic breast cancer drugGland Pharma has received approval from the USFDA to market a generic medication for breast cancer treatment, Eribulin Mesylate Injection. ...
- Gland Pharma's Hyderabad unit gets one observation from USFDA after inspection"This observation is procedural in nature and the corrective and preventive actions for this observation will be submitted to the USFDA wit...
- Sun Pharma, Hetero recall drugs in US marketAs per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...
- Gland Pharma launches generic cancer treatment drug in USThe Hyderabad-based company said its product is therapeutically equivalent to Takeda Pharmaceuticals' Velcade for Injection.
- Jefferies sees up to 21% upside in these two pharma stocksIt has a target of Rs 4,566 on Gland Pharma, valuing the stock at 36.5 times FY24 EPS, in line with its historical one-year forward of 37 t...
- Gland Pharma gets tentative nod from USFDA for generic Sugammadex injectionThe company "has received tentative approval from the United States Food and Drug Administration (USFDA) for Sugammadex injection, 200 mg/2...
- Gland has a robust business, and some risks you need to factor inALL POSITIVES fully priced in, which leaves little on the table; Chinese ownership comes with growth opportunities and potential shocks
- Zydus Cadila gets USFDA nod to market Doxazosin tabletsThe company has also received the tentative approval from the USFDA to market Lurasidone Hydrochloride Tablets in the strengths of 20 mg, 4...
- Zydus Cadila gets USFDA nod to market Doxazosin tabletsThe company has also received the tentative approval from the USFDA to market Lurasidone Hydrochloride Tablets in the strengths of 20 mg, 4...
- Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in USDr Reddy's is developing its injectable business and recently launched Paricalcitol injection, a therapeutic equivalent generic version of ...
- USFDA nods to Indian drugs up 84% in 1 yearInterestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...
- Torrent Pharma in talks to buy Glochem Industries for Rs 300 croreGlochem is a medium-sized company that makes bulk drugs, or active ingredients, which are used as raw material for medicines.
Load More
